The Abu Dhabi Ministry of Health (DoH) has signed an agreement with Illumina, a global leader in DNA sequencing and array-based technologies to advance precision medicine and clinical genomics research.

According to Amac News: The Abu Dhabi Ministry of Health said that the aim of this partnership is to develop the expertise, infrastructure and skilled workforce necessary for the integration of genomics into clinical practice and translational research at the local and international levels.
The agreement was signed during the BIO 2024 International Convention in the United States, in the presence of Mansoor Ebrahim AlMansoori, the head of the Ministry of Health, and Jacob Tysen, the CEO of Illumina.
The agreement was signed by Dr. Asma Ebrahim AlManaei, Executive Director of the Research and Innovation Center at the Ministry of Health, and Steve Barnard, Illumina's Chief Technology Officer.
Led by the Ministry of Foreign Affairs, a high-level Abu Dhabi delegation headed by Al Mansoori visited the United States between May 29 and June 5 to showcase the UAE's partnership opportunities and collaboration with leading organizations in research and development (R&D), manufacturing and innovation. to check
Using Abu Dhabi's abundant genomic data, the Ministry of Health and Illumina seek to accelerate innovations in genomics and precision medicine, with a focus on emerging genomic applications. It includes advanced genome and multi-omics analysis and interpretation to promote the development of new diagnostics for precision medicine and benefit patients locally and globally.